Sir Simon Campbell | |
---|---|
Born | Simon Fraser Campbell March 27, 1941 Lapal, England, United Kingdom |
Alma mater | University of Birmingham (BSc, PhD) |
Awards | |
Scientific career | |
Institutions | |
Thesis | Elimination processes in polyfluorocycloalkanes (1966) |
Sir Simon Fraser Campbell (born 27 March 1941) is a British chemist. [1]
Campbell was born on 27 March 1941 in Lapal, England. [3] He obtained a first-class BSc degree in Chemistry in 1962, a PhD degree in 1965, and an honorary DSc degree in 2004 from the University of Birmingham .
He was President of the Royal Society of Chemistry from 2004 to 2006. [1] He led innovative research, discovering some of the world's best-selling prescription drugs, including sildenafil, amlodipine, and doxazosin. [4] He was visiting lecturer at Universidade de São Paulo.[ citation needed ] He was a medicinal chemist for Pfizer. [5] He was visiting professor at University of Leeds, and on the advisory board of University of Kent, and University of Bristol. [6]
Campbell was knighted in the 2015 New Year Honours for services to chemistry, [7] [8] having previously been made a Commander of the Order of the British Empire (CBE).
Post-nominal letters, also called post-nominal initials, post-nominal titles, designatory letters, or simply post-nominals, are letters placed after a person's name to indicate that the individual holds a position, an academic degree, accreditation, an office, a military decoration, or honour, or is a member of a religious institute or fraternity. An individual may use several different sets of post-nominal letters, but in some contexts it may be customary to limit the number of sets to one or just a few. The order in which post-nominals are listed after a name is based on rules of precedence and what is appropriate for a given situation. Post-nominal letters are one of the main types of name suffix. In contrast, pre-nominal letters precede the name rather than following it, such as addressing a physician or professor as "Dr. Smith".
The National Institute for Medical Research (NIMR), was a medical research institute based in Mill Hill, on the outskirts of north London, England. It was funded by the Medical Research Council (MRC);
Richard Henderson is a British molecular biologist and biophysicist and pioneer in the field of electron microscopy of biological molecules. Henderson shared the Nobel Prize in Chemistry in 2017 with Jacques Dubochet and Joachim Frank. "Thanks to his work, we can look at individual atoms of living nature, thanks to cryo-electron microscopes we can see details without destroying samples, and for this he won the Nobel Prize in Chemistry."
Steven Victor Ley is Professor of Organic Chemistry in the Department of Chemistry at the University of Cambridge, and is a Fellow of Trinity College, Cambridge. He was President of the Royal Society of Chemistry (2000–2002) and was made a CBE in January 2002, in the process. In 2011, he was included by The Times in the list of the "100 most important people in British science".
Dame Carol Vivien Robinson, is a British chemist and former president of the Royal Society of Chemistry (2018–2020). She was a Royal Society Research Professor and is the Dr Lee's Professor of Physical and Theoretical Chemistry, and a professorial fellow at Exeter College, University of Oxford. She is the founding director of the Kavli Institute for Nanoscience Discovery, University of Oxford, and she was previously professor of mass spectrometry at the chemistry department of the University of Cambridge.
Mariann Bienz, Lady Pelham is a Swiss-British molecular biologist based at the UK Medical Research Council Laboratory of Molecular Biology. She has been a member of their Senior Scientific Staff since 1991, was Joint-head of Cell Biology in 2007-08 and has been a Group Leader of Protein and Nucleic Acid Chemistry Division since 2008.
Tomas Robert Lindahl is a Swedish-British scientist specialising in cancer research. In 2015, he was awarded the Nobel Prize in Chemistry jointly with American chemist Paul L. Modrich and Turkish chemist Aziz Sancar for mechanistic studies of DNA repair.
Martin Bobrow is a British geneticist, and Emeritus Fellow, Wolfson College, Cambridge.
Anthony Ledwith was a British chemist.
Dame Anne Jane Mills, is a British authority on health economics. She is deputy director and Provost and Professor of Health Economics and Policy at the London School of Hygiene and Tropical Medicine.
Sir David Allan "Dai" Rees, FRS was a British biochemist and science administrator who was chief executive of the Medical Research Council between 1987 and 1996.
Richard Nelson Perham, FRS, FMedSci, FRSA, was Professor of biochemistry at the University of Cambridge, and Master of St John's College, Cambridge 2004–07. He was also editor-in-chief of FEBS Journal from 1998 to 2013.
Sheena Elizabeth Radford is a British biophysicist, and Astbury Professor of Biophysics and a Royal Society Research Professor in the Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology at the University of Leeds. Radford is the Associate Editor of the Journal of Molecular Biology.
Trevor Mervyn Jones, CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW is a visiting professor at King's College London, and a former Head of R&D, at Wellcome. He continues to have a distinguished career in the pharmaceutical and biotech industry as well as in academia.
Jane Clarke is a British biochemist and academic. Since October 2017, she has served as President of Wolfson College, Cambridge. She is also Professor of Molecular Biophysics, a Wellcome Trust Senior Research Fellow in the Department of Chemistry at the University of Cambridge. She was previously a Fellow of Trinity Hall, Cambridge. In 2023, she was elected to the National Academy of Sciences.
David Charles Rees CChem FRSC FMedSci is a chemist recognised internationally for his innovative use of chemistry in drug discovery. He is Chief Scientific Officer of biotechnology company Astex Pharmaceuticals, which is located in Cambridge, UK.
Fiona Hamilton Marshall is a British pharmacologist, biotech-founder and President of Biomedical Research at Novartis. She founded and previously served as Chief Scientific Officer at Heptares Therapeutics, which was acquired by the Japanese biopharmaceutical company Sosei, where she served as Vice President. She was elected Fellow of the Academy of Medical Sciences in 2016 and the Royal Society in 2021.
Andrew Lee Hopkins is a Welsh scientist who is the founder and former CEO of the pharmaceutical company Exscientia, which develops drugs using artificial intelligence.